Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin Therapeutic Drug Monitoring in Gram Positive Bacterial Infection
ChiCTR-OPC-16007920Phase 4Completed
- Sponsor
- Huashan Hospital
- Start
- Sep 2012
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vancomycin in Gram-positive bacterial infection, sponsored by Huashan Hospital. Primary endpoint: Serum vancomycin concentration. Started Sep 2012; status: completed.
02
Drugs
vancomycin
03
Conditions
Gram-positive bacterial infection
Beyond the preview
Go deeper on ChiCTR-OPC-16007920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16007920.